中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2014年
6期
1077-1078
,共2页
红细胞生成素%风湿免疫系统%贫血
紅細胞生成素%風濕免疫繫統%貧血
홍세포생성소%풍습면역계통%빈혈
Erythropoietin%Rheumatoid immune system%Anemia
目的:探究分析红细胞生成素(EPO)水平和风湿免疫系统疾病两者之间的关系,以便更加深入地了解风湿免疫系统疾病患者对于红细胞生成素的反应。方法:选自我院2008~2012年收治的风湿免疫系统疾病患者共50例,设为A组,同期缺铁性贫血(IDA)患者共50例,设为B组,并与我院同期体检结果显示为正常的健康人共50例,设为C组。对比三组人血常规、乳酸脱氢酶、肝肾功能以及网织红细胞计数等各项指标。结果:A组患者的血清EPO水平,相对于B组患者要低很多,两者具有显著差异性(P<0.05)。结论:风湿免疫系统疾病因为红细胞生成素有所降低,导致出现合并贫血症状疾病,对于此类患者应用红细胞生成素治疗方法有较为突出的临床治疗效果。
目的:探究分析紅細胞生成素(EPO)水平和風濕免疫繫統疾病兩者之間的關繫,以便更加深入地瞭解風濕免疫繫統疾病患者對于紅細胞生成素的反應。方法:選自我院2008~2012年收治的風濕免疫繫統疾病患者共50例,設為A組,同期缺鐵性貧血(IDA)患者共50例,設為B組,併與我院同期體檢結果顯示為正常的健康人共50例,設為C組。對比三組人血常規、乳痠脫氫酶、肝腎功能以及網織紅細胞計數等各項指標。結果:A組患者的血清EPO水平,相對于B組患者要低很多,兩者具有顯著差異性(P<0.05)。結論:風濕免疫繫統疾病因為紅細胞生成素有所降低,導緻齣現閤併貧血癥狀疾病,對于此類患者應用紅細胞生成素治療方法有較為突齣的臨床治療效果。
목적:탐구분석홍세포생성소(EPO)수평화풍습면역계통질병량자지간적관계,이편경가심입지료해풍습면역계통질병환자대우홍세포생성소적반응。방법:선자아원2008~2012년수치적풍습면역계통질병환자공50례,설위A조,동기결철성빈혈(IDA)환자공50례,설위B조,병여아원동기체검결과현시위정상적건강인공50례,설위C조。대비삼조인혈상규、유산탈경매、간신공능이급망직홍세포계수등각항지표。결과:A조환자적혈청EPO수평,상대우B조환자요저흔다,량자구유현저차이성(P<0.05)。결론:풍습면역계통질병인위홍세포생성소유소강저,도치출현합병빈혈증상질병,대우차류환자응용홍세포생성소치료방법유교위돌출적림상치료효과。
To explore the analysis of erythropoietin (EPO) level and rheumatoid disease,the relationship between the immune system,in order to more in-depth understanding of erythropoietin in patients with rheumatoid immune system disease.Methods:To choose self institute of rheumatism admitted in 2008~2012,A total of 50 patients with diseases of the immune system,as A group,in the same period,A total of 50 patients with iron deficiency anemia (IDA),set to group B,and over the same period of our hospital check-up result shows that for A total of 50 cases of normal healthy people and set as group C. Compared three groups of blood routine,lactate dehydrogenase,hepatorenal function and reticulocyte count and other indicators.Results:The serum EPO level in patients of group A,compared with group B patients were much lower,which has significant difference (P<0.05).Conclusion:Rheumatoid immune system disease because of erythropoietin is reduced,cause disease in the merger of anemia symptoms,erythropoietin treatment for such patients have a more prominent clinical curative effect.